Encodia is a rapidly growing platform company that is developing a new generation of protein analysis tools based on single-molecule protein sequencing. Our goal is to make protein sequencing easy and ubiquitous by using a novel reverse-translation technology that turns peptide sequences into DNA. The DNA can be read by a DNA sequencer, providing a path to breakthrough proteomics research at a scale that is not practical or cost-effective using current technologies.

---

---

Encodia’s founders have extensive experience inventing and developing commercially successful platform technologies and assays. We have recruited a talented team dedicated to realizing an integrated, user-friendly system that will analyze protein samples on an unprecedented scale.